Single dose ofloxacin in treatment of uncomplicated gonorrhoea. 1986

A S Chan, and K C Tang, and K K Fung, and T K Ng

78 patients (66 male and 12 female) suffering from uncomplicated gonorrhoea were randomly selected to receive a single oral dose of either 400 mg or 600 mg ofloxacin. Of the 59 patients completely followed up penicillinase-producing Neisseria gonorrhoeae strains were cultured in 15 (25.4%) and the overall cure rate was 100%. Both groups showed excellent clinical effectiveness in over 80% and adverse reactions were uncommon and transient. We conclude that a single oral dose of ofloxacin in the studied dosage regimens was highly effective and safe in the treatment of uncomplicated gonorrhoea.

UI MeSH Term Description Entries
D008297 Male Males
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006069 Gonorrhea Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. Neisseria gonorrhoeae Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280

Related Publications

A S Chan, and K C Tang, and K K Fung, and T K Ng
January 1987, Drugs,
A S Chan, and K C Tang, and K K Fung, and T K Ng
January 1994, International journal of STD & AIDS,
A S Chan, and K C Tang, and K K Fung, and T K Ng
October 1986, Genitourinary medicine,
A S Chan, and K C Tang, and K K Fung, and T K Ng
January 1986, Infection,
A S Chan, and K C Tang, and K K Fung, and T K Ng
April 1975, The British journal of venereal diseases,
A S Chan, and K C Tang, and K K Fung, and T K Ng
December 1989, The American journal of medicine,
A S Chan, and K C Tang, and K K Fung, and T K Ng
July 1976, The New Zealand medical journal,
A S Chan, and K C Tang, and K K Fung, and T K Ng
January 1971, Acta dermato-venereologica,
A S Chan, and K C Tang, and K K Fung, and T K Ng
March 1987, The Medical journal of Australia,
A S Chan, and K C Tang, and K K Fung, and T K Ng
August 1986, European journal of clinical microbiology,
Copied contents to your clipboard!